CSI Market
Sign In | Register

Genomic Health Inc (GHDX) Annual Cash Flow Statement

Annual · GAAP · USD millions
Access GHDX quarterly Cash Flow →
The cash flow figures below highlight longer-term patterns in how Genomic Health Inc manages cash inflows and outflows over time.
View historic periods: Download as CSV:
Download as CSV
Commercial Data Licensing & OEM
Annual commercial subscriptions for corporate use, internal BI systems, management reporting, AI integration, and client-facing platforms
API & Data Feeds
Programmatic access to normalized fundamentals & ratios.
Annual Report, GAAP in USD millions
ITEM 		(Dec 31 2018)
12 Months 		(Dec 31 2017) (Dec 31 2016) (Dec 31 2015) (Dec 31 2014)
Operating Activities
Income25.68
Depreciation & amortization12.67
Amortization of Other Assets0.00
Increase (Decrease) in Deferred Revenue0.00
Impairment of Long-Lived Assets to be Disposed of2.36
Provision For Loan Losses Expensed0.00
Inventories Decrease /-Increase0.00
R & D, Environmental and Other Expense0.00
Gain (Loss) on Disposition of Property Plant Equipment0.03
Share-based Compensation21.29
Income (Loss) from Equity Method Investments0.00
Financial Instruments and Foreign Currency Transaction0.00
Write Off Of Previously Capitalized Costs-
Available For Sale Securities Gross Realized Gains-
Investment Income Net Amortization Of Discount And Premium-
Capitalized Computer Software Impairments2.35
Equity Securities Fv Ni Realized Gain-
Debt Securities Available For Sale Realized Gain Loss-
Increase Decrease In Contract With Customer Liability-
Income taxes0.00
Losses/ -gains on Investments net0.00
Accounts Receivable3.26
Increase (Decrease) in Accounts Payable8.37
Increase (Decrease) in Accrued Liabilities and Other Operating Liabilities2.57
Deferred Revenue and Customer Advances and Deposits0.00
Increase (Decrease) in Prepaid Expense and Other Assets-2.46
Other Working Capital0.00
Other Noncash Income (Expense)0.00
Other net0.00
Payments for (Proceeds from) Other Operating Activities0.45
Discontinued operations0.00
Net Cash flow from Operating Activities76.56
Investing Activities
Capital Expenditures-10.08
Sale of Capital Items0.06
Proceeds from Sale of Available-for-sale Securities, Debt0.00
Payments to Acquire Marketable Securities-172.56
Real Estate Investments0.00
Proceeds From Maturity Of Marketable Securities103.98
Proceeds From Sale Of Marketable Securities-
Restricted Cash and Investments Increase (Decrease)0.00
Payments for (Proceeds from) Loans0.00
Payments for (Proceeds from) Deposits0.00
Payments to Acquire Other Investments-2.50
Payments for (Proceeds from) Federal Reserve and FHLB0.00
Acquisition Net of Cash Acquired0.00
Interest in Subsidiaries and Affiliates0.00
Sale of businesses0.00
Accounts payable0.00
Receivables0.00
Payments for (Proceeds from) Other Investing Activities0.00
Other Net0.00
Discontinued operations0.00
Net Cash Flow from Investing Activities-81.11
Financing Activities
Short-term debt Net0.00
Other borrowing transactions0.00
Long-term debt - borrowings0.00
Long-term debt - repayments0.00
Federal Home Loan Bank and Federal Funds0.00
Issuances / -repurchases of Comm. Stock26.25
Partnership and Parent Transactions0.00
Issuances / -repurchases of Pref. Stock0.00
Deposits, Annuities, Contract Holders Funds0.00
Other financing activities net0.00
Other net-5.50
Finance Lease Principal Payments-
Payments of Dividends, Preferred Stock and Preference Stock0.00
Dividends paid0.00
Net Cash Flow from Financing Activities20.75
Effect of exchange rate on cash flow16.21
Discontinued operations0.00
Free Cash Flow66.54
Total Cash Flow16.21
4 historic quarters locked

Sign in to unlock the full Genomic Health Inc cash flow history.

Sign In Create Free Account

About GHDX Annual Cash Flow Statement

What this statement shows

This page presents issuer-reported cash flow data, including operating, investing, financing, net, and free cash flow, as disclosed in SEC 10-K filings and normalized by CSIMarket.

Source & verification

  • Form: 10-K
  • Filed with the SEC: n/a

Last updated

  • Page updated:
  • Data lineage: SEC filings - XBRL extraction - normalization in the CSIMarket.com database.

Figures are derived from filed reports and may be restated. Historical data is subject to revision.

Untitled Document 





                    


    



  Get the full CSIMarket dataset:
  Subscribe
  API
  License